These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26762489)

  • 1. Masked Hypertension in Low-Income South African Adults.
    Ware LJ; Rennie KL; Gafane LF; Nell TM; Thompson JE; Van Rooyen JM; Schutte R; Schutte AE
    J Clin Hypertens (Greenwich); 2016 May; 18(5):396-404. PubMed ID: 26762489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
    Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
    Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
    Tang H; Gong WY; Zhang QZ; Zhang J; Ye ZC; Peng H; Wang C; Lou T
    Nephrology (Carlton); 2016 Oct; 21(10):841-50. PubMed ID: 26566951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar levels of low-grade inflammation and arterial stiffness in masked and white-coat hypertension: comparisons with sustained hypertension and normotension.
    Andrikou I; Tsioufis C; Dimitriadis K; Syrseloudis D; Valenti P; Almiroudi M; Lioni L; Tousoulis D; Stefanadis C
    Blood Press Monit; 2011 Oct; 16(5):218-23. PubMed ID: 21914984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Masked hypertension, rather than white-coat hypertension, has a prognostic role in patients with non-dialysis chronic kidney disease.
    Wang C; Zhang J; Li Y; Ma X; Ye Z; Peng H; Lou T
    Int J Cardiol; 2017 Mar; 230():33-39. PubMed ID: 28034462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical outcomes of white-coat and masked hypertension: Analysis of a large ambulatory blood pressure database.
    Tocci G; Presta V; Figliuzzi I; Attalla El Halabieh N; Battistoni A; Coluccia R; D'Agostino M; Ferrucci A; Volpe M
    J Clin Hypertens (Greenwich); 2018 Feb; 20(2):297-305. PubMed ID: 29370477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Masked hypertension and its associated cardiovascular risk in young individuals: the African-PREDICT study.
    Thompson JE; Smith W; Ware LJ; M C Mels C; van Rooyen JM; Huisman HW; Malan L; Malan NT; Lammertyn L; Schutte AE
    Hypertens Res; 2016 Mar; 39(3):158-65. PubMed ID: 26606873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Masked hypertensives: A disguised arterial stiffness population.
    Antza C; Doundoulakis I; Stabouli S; Tziomalos K; Kotsis V
    J Clin Hypertens (Greenwich); 2019 Oct; 21(10):1473-1480. PubMed ID: 31498516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White-coat and masked hypertension are associated with albuminuria in a general population: the Hisayama Study.
    Hata J; Fukuhara M; Sakata S; Arima H; Hirakawa Y; Yonemoto K; Mukai N; Kitazono T; Kiyohara Y; Ninomiya T
    Hypertens Res; 2017 Nov; 40(11):937-943. PubMed ID: 28878300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.
    Drawz PE; Alper AB; Anderson AH; Brecklin CS; Charleston J; Chen J; Deo R; Fischer MJ; He J; Hsu CY; Huan Y; Keane MG; Kusek JW; Makos GK; Miller ER; Soliman EZ; Steigerwalt SP; Taliercio JJ; Townsend RR; Weir MR; Wright JT; Xie D; Rahman M;
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):642-52. PubMed ID: 26912547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, predictive factor, and clinical significance of white-coat hypertension and masked hypertension in Korean hypertensive patients.
    Hwang ES; Choi KJ; Kang DH; Nam GB; Jang JS; Jeong YH; Lee CH; Lee JY; Park HK; Park CH
    Korean J Intern Med; 2007 Dec; 22(4):256-62. PubMed ID: 18309684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain.
    Gijón-Conde T; Graciani A; López-García E; Guallar-Castillón P; García-Esquinas E; Rodríguez-Artalejo F; Banegas JR
    Hypertens Res; 2017 Jun; 40(6):613-619. PubMed ID: 28179625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of demographic, clinical, and laboratory parameters between patients with sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension.
    Afsar B
    J Cardiol; 2013 Mar; 61(3):222-6. PubMed ID: 23294898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension defined by the 2017 ACC/AHA guideline is more accurate than 2018 ESC/ESH for detecting early vascular aging in young adults.
    de Souza MP; Lopes PC; Bazo G; Rocha PRH; Lorencini DA; Bettiol H; Barbieri MA; Coelho EB
    Medicine (Baltimore); 2022 Feb; 101(6):e28841. PubMed ID: 35147130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of white-coat and masked hypertension in chronic kidney disease and end-stage renal disease.
    Boggia J; Silvariño R; Luzardo L; Noboa O
    Hypertens Res; 2014 Oct; 37(10):882-9. PubMed ID: 24739541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical arterial damage in untreated masked hypertensive subjects detected by home blood pressure measurement.
    Matsui Y; Eguchi K; Ishikawa J; Hoshide S; Shimada K; Kario K
    Am J Hypertens; 2007 Apr; 20(4):385-91. PubMed ID: 17386344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term risk of sustained hypertension in white-coat or masked hypertension.
    Mancia G; Bombelli M; Facchetti R; Madotto F; Quarti-Trevano F; Polo Friz H; Grassi G; Sega R
    Hypertension; 2009 Aug; 54(2):226-32. PubMed ID: 19564548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study.
    Sivén SS; Niiranen TJ; Kantola IM; Jula AM
    J Hypertens; 2016 Jan; 34(1):54-60. PubMed ID: 26630213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease.
    Scheppach JB; Raff U; Toncar S; Ritter C; Klink T; Störk S; Wanner C; Schlieper G; Saritas T; Reinartz SD; Floege J; Janka R; Uder M; Schmieder RE; Eckardt KU; Schneider MP
    Hypertension; 2018 Oct; 72(4):929-936. PubMed ID: 30354716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Masked Hypertension Among US Adults With Nonelevated Clinic Blood Pressure.
    Wang YC; Shimbo D; Muntner P; Moran AE; Krakoff LR; Schwartz JE
    Am J Epidemiol; 2017 Feb; 185(3):194-202. PubMed ID: 28100465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.